A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report

Producción científica: Contribución a una revistaArtículoInvestigaciónrevisión exhaustiva

110 Citas (Scopus)

Resumen

Few studies have reported large inter-observer variations in target volume selection and delineation in patients treated with radiotherapy for head and neck squamous cell carcinoma. Consensus guidelines have been published for the neck nodes (see Grégoire et al., 2003, 2014), but such recommendations are lacking for primary tumour delineation. For the latter, two main schools of thoughts are prevailing, one based on geometric expansion of the Gross Tumour Volume (GTV) as promoted by DAHANCA, and the other one based on anatomical expansion of the GTV using compartmentalization of head and neck anatomy.
Idioma originalInglés
Páginas (desde-hasta)206-225
Número de páginas19
PublicaciónEuropean Journal of cancer
Volumen81
DOI
EstadoPublicación electrónica previa a su impresión - jun 2017

Huella

Profundice en los temas de investigación de 'A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report'. En conjunto forman una huella única.

Citar esto